Lanadelumab 300mg/2ml solution for injection vials
- SNOMED code
37762611000001109- Active compound
- Lanadelumab
- Preferred name basis
- rINN - Recommended International Non-proprietary
- Prescribable
- ✅ Yes
- Non-availability
- Actual Products not Available
- Non-availability date
- Dose form
- Discrete
- Dose size and units
- 2 ml, vial
- Ingredients
- Lanadelumab
— 150 mg
/ 1 ml
based on ingredient substance
- Form & Route
- solutioninjection.subcutaneous
Solution for injection, Subcutaneous - Controlled drug
- No Controlled Drug Status
Products
Takhzyro 300mg/2ml solution for injection vials (Takeda UK Ltd)
Takhzyro 300mg/2ml solution for injection vials
- SNOMED code
37733711000001102- Supplier
- Takeda UK Ltd
- Licensed as
- Medicines - MHRA/EMA
- Availability restrictions
- Not available
- Licensed route
- Subcutaneous
| Pack name & code | Status | GTIN, EAN barcodes | Price | Prescribing | Reimbursement | Pack |
|---|---|---|---|---|---|---|
Takhzyro 300mg/2ml solution for injection vials (Takeda UK Ltd) 1 vial37733911000001100 ref. pack |
Discontinued
Legal category: POM | 05060147027587 | No Price Available previously: £12,420 | • Hospital |
| — |
Reference packs
Lanadelumab 300mg/2ml solution for injection vials 1 vial
- SNOMED code
37733611000001106- Quantity and unit
- 1 vial
- Packs